New Issues
If you would like to view some of our recent IPOs, please go to current activities.
A key element of Blomfield's services is our ability to enable companies to access the equity and debt finance they need to fund growth. We have played a leading role in successful flotations on the UK Listing Authority’s Full List, the AIM Market of the London Stock Exchange and on Ofex. We can also arrange pre IPO finance for clients.
We do not stop our involvement when we float our clients; we expect to continue to advise them into the future, assisting them in their development, as further capital for growth is required.
Blomfield has built up a good reputation over the years through careful selection of the companies and the management teams it supports.
Case Studies
Recent:
RedHot Media International Limited
RedHot Media International Limited is the holding company of the RedHot Media Group – which is predominantly engaged in media broking, including an innovative barter sales trading activity involving advertisement space as a currency in exchange for advertisers’ products and services. Blomfield acted as Nominated Adviser to RedHot Media International on it’s admission to AIM on 26 September 2008. On admission, RedHot Media International had a market capitalisation of £29.6 million. Since admission to AIM, RedHot Media International has completed three acquisitions.
The Family Shari’ah Fund Limited
Blomfield acted as Nominated Adviser and Broker to The Family Shari’ah Fund on its admission to AIM on 25 July 2008, subsequent to a US$30 million fundraising. The Family Shari’ah Fund was the first Shari’ah Compliant multi asset-class investment company to be admitted to AIM.
Europe Steel plc
Blomfield acted as Rule 3 adviser to PLUS-quoted Europe Steel plc, advising the board of Europe Steel on the £6.36 million cash offer made by Ferrous Metal Company Limited.
Panceltica Holdings Limited
Panceltica is a fast track fabricator and constructor of residential and commercial units – including accommodation, modular buildings, commercial buildings and portable or sectional buildings. The Group uses Scottsdale Technology, owned by a Group company, to build lightweight Galvanized Steel framed structures – which results in logistical and time savings, as manufacture and assembly typically takes place on site. The Group’s current focus of construction projects is within the GCC group of countries. Blomfield acted as Nominated Adviser on Panceltica’s admission to AIM in March 2008, following US$115 million of pre-IPO funding. Panceltica had a market capitalisation of £236 million on admission and was, at the time of its admission to AIM, the largest AIM flotation of 2008.
Medgenics, Inc.
Blomfield Corporate Finance acted as Nominated Adviser to Medgenics in its admission to AIM in December 2007. Medgenics is developing a unique sustained-action therapeutic protein delivery technology for the treatment of a range of chronic diseases. The technology – called a “Biopump” – is made from the patient’s own skin and is implanted in a simple procedure to work inside the patient’s body, to produce and deliver the active protein steadily over a sustained period to treat the targeted disease. Medgenics has demonstrated proof-of-principle of its treatment procedure in a clinical trial using EPODURE in anemic patients. A long-acting version of EPODURE designed to Yproduce and deliver a therapeutic dose of EPO steadily for six months or more is scheduled to enter Phase I/II efficacy trials in Israel in mid-2008. Clinical trials with INFRADURE are intended follow in due course. Beyond this, the Company plans to develop a pipeline of products based on its Biopump technology targeting the large and rapidly growing global $50+ billion protein therapy market, which is expected to grow to some $87 billion per year in 2010.
Pennine Downing AIM VCT plc and The Ethical AIM VCT plc
Blomfield acted to Sponsor to both Pennine Downing AIM VCT plc and The Ethical AIM VCT plc in the merger of Pennine Downing AIM VCT plc, Pennine Downing AIM VCT 2 plc and The Ethical AIM VCT plc.
QPR Holdings Limited
Blomfield acted as Rule 3 adviser to QPR Holdings Limited, advising the board of QPR Holdings on the offer made by Sarita Capital Investment Inc – a newly formed company created for the purposes of the Offer. The Offer gave QPR Holdings an enterprise value of £14 million.
Tembusu Investments Limited
Blomfield Corporate finance acted as Nominated Adviser and Broker to Tembusu on its admission to AIM and £3 million fundraise in May 2007. Tembusu, an investment company, was established in order to identify and acquire quoted and unquoted businesses based in Asia, excluding Japan, whose growth is dependent upon the rapidly rising affluence of middle to upper income groups in the region. Most recently, Tembusu acquired a 1.085% stake in European Islamic Investment Bank PLC.
Nostra Terra Oil and Gas Company plc
Blomfield was Nominated Adviser to NTOG (formerly LHP Investments plc) on its reverse takeover of Nostra Terra (Overseas) Limited and admission to AIM in June 2007. Nostra Terra (Overseas) Limited was incorporated for the purpose of securing and exploiting three oil and gas licences in the Tarkhankut Peninsula located on the northwest reaches of the greater Crimean Peninsula of Ukraine. As of April 2008, NTOG had successfully brought several of the wells on its licences into production, and commenced the sale of oil.
The Core Business plc
Having acted as Nominated Adviser to Core on its admission to AIM in 2006, Blomfield acted for Core in its £2.6 million acquisition of Amirose International Limited, re-admission to AIM and associated £2.2 million fundraising in July 2007. The acquisition of Amirose provided Core with the opportunity of bringing its own portfolio of brands into Amirose's established distribution and logistics facility. Core also now has the ability to introduce Amirose's portfolio of brands including Pure Derm and Skin Benefits to its strong network of retail contacts in the UK and to develop products with Amirose's established Far Eastern supply chain contacts.
Galantas Gold Corporation
Blomfield acted as TSX-Venture Exchange listed Galantas’ Nominated Adviser in its admission and dual-listing on AIM in March 2006. Galantas has sole rights to a 189-square-kilometre prospecting licence and associated mining leases in County Tyrone, Ireland, which Galantas has successfully brought into production – Ireland’s only producing gold mine. Galantas adds value to the production by utilizing the rare Irish gold to fashion an exclusive line of high quality 18-carat gold jewellery.
Maypole Group plc
Maypole was originally incorporated with the intention of being an acquisition vehicle for UK countryside hotels with restaurants or pubs attached. Following Maypole’s third acquisition, Maypole reviewed its acquisition strategy and decided to focus on restaurant-led countryside hotels, As a result, the group sold assets such as pubs with no accommodation, and now owns and operates countryside hotels with an emphasis on good, locally-sourced food and a range of varied dining environments. The group now has 7 hotels and is looking to continue its growth with plans for further acquisitions. Blomfield acted as nominated adviser to Maypole in its admission to AIM in April 2006.
The flotation of Red Rock Resources plc on AIM and £476,000 fund raising
Red Rock is a mineral exploration and development company established to focus on advancing its iron ore and manganese projects in Western Australia and Tasmania. Blomfield acted as the company's nominated adviser and broker on the company's admission in July 2005.
The admission of Thor Mining to AIM and fund raising of £1.4 million
Thor has been established to develop its molybdenum and tungsten projects in the Northern Territory of Australia. Blomfield acted as the company's nominated adviser and broker on its admission in June 2005.
The flotation of Hallin Marine Subsea International Plc on AIM and £3.5 million fundraising
Hallin is involved in offshore sub-sea intervention primarily for blue chip clients in the oil, gas and telecommunication industries. Blomfield advised the company on its admission to AIM in April 2005.
The admission of Harbinger Capital PLC to AIM
Blomfield floated Harbinger on AIM in March 2005 and raised £500,000 of initial capital via a placing. Harbinger is an investment company and the money was raised to fund acquisitions of businesses providing specialist finance and services to SMEs.
The AIM introduction of Regency Mines PLC
Blomfield advised Regency Mines PLC on its introduction to AIM in 2005. Regency Mines PLC invests in the mining and minerals sectors including base metals and precious metals exploration in Australia.
The flotation of Lennox Holdings PLC on AIM and £4 million fundraising
Lennox Holdings PLC imports and distributes a range of British products to Spanish supermarkets which serve the expatriate community and tourists. It is intended to make acquisitions in the food and drink retail industry in Europe. Blomfield advised Lennox on its admission to AIM and £4 million fundraising.
The reverse take-over of Packpress Limited by Systems Integrated Research plc (SiRViS IT plc), admission to AIM and £3.8 million fundraising
Blomfield advised SiRViS IT on the reverse take-over of Packpress Limited which provides IT services including support, consultancy and systems installation to over 4,500 customer sites across the UK. £3.8 million was raised via a placing to fund the acquisition.
The reverse take-over of SCOTTY Tele-Transport Corporation AG by Motion Media PLC, associated fundraising of £5 million and re-admission to AIM
Blomfield provided advice to Motion Media on the reverse take-over of SCOTTY, an Austrian developer and supplier of videoconferencing systems that enable real-time audio, video and data communication via the Inmarsat satellite network and other broadband networks, primarily to the military market. £5 million was raised by way of a placing in order to provide the combined group with additional working capital.
Earlier:
The flotation of Motion Media PLC
In 1996 Blomfield raised £1 million for Motion Media and floated it on OFEX. After a subsequent interim fund raising in 1997, Blomfield acted as adviser and sponsor for Motion Media's IPO on the Official List, raising £18 million of equity finance. In early 2003 under difficult market conditions we moved the company to AIM and raised a further £3 million of equity finance. In 2004 we raised a further £5 million for the Company as it acquired SCOTTY, an Austria based group involved in the military side of videocommunications.
The flotation of BioFocus PLC
Blomfield acted as nominated adviser in BioFocus' move to AIM in August 2000 raising £4 million of capital to fund further expansion and possible acquisitions.
Previously Blomfield assisted in the formation of the business in 1996, raising £1 million for the company and floated it on OFEX. We raised additional funds in 1998, which proved to be a watershed in the development of the company. BioFocus provides pharmaceutical and biotechnology companies with integrated chemistry services, including the design and synthesis of chemicals involved in the drug discovery process. BioFocus also provides its clients with specialised libraries of compounds for targeted drug discovery. Blomfield floated the company on AIM in 2000 and advised on its acquisition of Cambridge Drug Discovery in 2001.
The flotation of NextFifteen Communications Group PLC
NextFifteen is Europe's largest specialist Information Technology PR group. Blomfield introduced NextFifteen (then called Text 100 Group) on to OFEX in 1997, in 1999 we floated the group on the Official List and raised £1 million of equity finance helping to finance further growth.
